Conference Coverage

Time to scrap LMWH for prevention of placenta-mediated pregnancy complications?


 

REPORTING FROM THSNA 2018


Revisiting the hypothetical case of a 32-year-old woman with prior severe preeclampsia who delivered at 32 weeks, Dr. Rodger said that he would “definitely not” recommend LMWH during her next pregnancy.

He acknowledged limitations of the systematic review, including the limited numbers of patients in subgroups and the large differences between single-center and multicenter trials. “We still can’t explain this, and it remains an open question that bugs me,” he said. “This has been seen in many disease areas. Empirically, single-centeredness leans toward positivity.”

He called for more research in women with recurrent pregnancy loss. Dr. Rodger reported having no financial disclosures.

Pages

Recommended Reading

Bariatric surgery may adversely affect newborns
MDedge Internal Medicine
Interventions urged to stop rising NAS, stem Medicaid costs
MDedge Internal Medicine
FDA approves certolizumab label update for pregnancy, breastfeeding
MDedge Internal Medicine
Axial SpA disease activity remains mostly stable throughout pregnancy
MDedge Internal Medicine
MDedge Daily News: Why most heart failure may be preventable
MDedge Internal Medicine
Higher preconception blood pressure linked to pregnancy loss
MDedge Internal Medicine
Reassurance for women taking certolizumab during pregnancy
MDedge Internal Medicine
Zika virus: Sexual contact risk may be limited to short window
MDedge Internal Medicine
Studying the gestational diabetes risk associated with endocrine-disrupting chemicals
MDedge Internal Medicine
Hints of altered microRNA expression in women exposed to EDCs
MDedge Internal Medicine